Responsibility for product

Operating within the pharmaceutical industry, we accept our responsibility for human health and life. That is why the quality of our products and the safety of patients are our priorities.

Woman doing laboratory tests
  • We care for quality at each stage of product development, production, storage, distribution and sale.
  • Our products are manufactured in accordance with the highest standards of Good Manufacturing Practice (GMP).
  • We have GMP certificates issued by the Main Pharmaceutical Inspectorate for all drugs and substances manufactured.
  • We use the latest technologies to ensure the safety of products, employees and the natural environment.


We ensure continuous pharmacovigilance to minimise any risks involved in the use of our products. A designated company department collects, analyses and archives notifications of adverse effects in all markets in which our products are used. We examine the reasons, evaluate the risk/benefit ratio of the use of a medicine, and implement risk mitigating measures. We are included in the European system of electronic reporting of adverse effects – EudraVigilance.

Ethical marketing

We are co-authors and signatories of the Code of Pharmaceutical Marketing Ethics of the Polish Association of Pharmaceutical Industry Employers. Our marketing activities are conducted with integrity and reliability and always in accordance with the ethical principles outlined in the Code.

We provide verified and reliable information in an explicit and objective way. We monitor the quality of our marketing activities, and we accept responsibility for the constant raising of standards in this respect.

We ensure that we provide reliable and clear information about our products and their effects.

The contents of the patient leaflet are compliant with the results of “clarity tests”, i.e. consultations with target groups of users of the medicinal product, and we ensure that patients use the leaflet correctly and safely. A patient must be able to FIND the information contained in the leaflet, UNDERSTAND it and KNOW HOW TO DEAL WITH IT.

New product packaging

In 2018, in cooperation with pharmacists, we implemented a new prescription drug packaging system, which aims to increase the readability of packaging, minimise the risk of drug dispensing, and increase patient safety.

System pakowania

The new prescription drug packaging offered by Polpharma Group (including Polpharma, Medana and Polfa Warszawa) was created on the basis of interviews with patients and pharmacists, who have been consulted every step of the way. The change also forms part of a strategic process of unification of the Polpharma Group brand, which the company launched to consolidate its portfolio worldwide.

The main idea behind the new packaging design is to make it more functional. The design takes into account how the packaging is arranged on shelves and in drawers at the pharmacy, the specifics of pharmacists’ work, as well as the needs of elderly and visually-impaired patients.

Five features of the new packaging design that minimise the risk of drug dispensing errors at pharmacies and improve convenience for pharmacists:

  1. Dosage colour-coding reduces the risk of errors.
  2. Drug name and dosage information written in large print makes it easier to differentiate between drug names and dosage information.
  3. Drug name and dosage information featured on three sides of the packaging – as the space in pharmacy drawers is limited, the information is now visible regardless of how the packagings is arranged (horizontally, vertically or flat on the shelf).
  4. A drug use table offers space for the pharmacist or patient to note down when a particular drug should be taken.
  5. Colour-coding of particular therapeutic groups makes it easier to catalogue the drugs at the pharmacy.

For patient safety

  1. Colour-coding and clear font used for drug name and dosage information makes things easier for the elderly and visually-impaired.
  2. A drug use table (on the back) offers space to write down when the drug should be taken, which improves patient compliance.
  3. Key information (name, dosage, content) visible on three sides of the packaging makes it easier to find the drug in the medicine drawer at home.

Why the change?

Polpharma, as a socially responsible company, offers a rich drug portfolio but also respects its sustainable commitments which help patients and pharmacists manage the health of Polish residents. The new graphic design was developed to make the packaging more functional and safer for pharmacists and patients. It also form part of a process of unification of the entire Polpharma Group brand, which involves the company’s portfolio consolidation across its branches worldwide.

Positive reception

The new prescription drug packaging system offered by Polpharma has been praised by pharmacists as well-conceived, functional, clear and trustworthy. This December, Polpharma received an award for the Rx drug packaging rebranding project in the Launch/Rebranding of the Year category in the Marketing Directorof the Year 2018 competition. The Rx drug packaging rebranding project was also positively reviewed by the Polish Pharmaceutical Chamber and was welcomed by pharmacists themselves, who praised the well-conceived and functional design which will make their everyday work easier.


Product information

We care about reliable and transparent information about our products.

Facilities for visually impaired people

In order to meet the needs of blind and visually impaired people, we provide leaflets for our medicines in an audio form through the Audio Leaflet system by MEDsynC (phone number 800 706 848). This system has been developed in cooperation with the Polish Association of the Blind and obtained its recommendation as a product appropriate for persons with vision disorders.


The Polish Association of the Blind sent the following thanks to Polpharma:

Thanks to the Audio Leaflet we may access information about a selected medicine in a quick, safe, free and generally accessible way. The hotline system is simple to operate, it may be used without the participation of third parties. We believe that the provision of access to the contents of leaflets on medicinal products is the expression of concern about the problems of blind people.

In accordance with European Union requirements, the packaging of our medicines is also described using the Braille system (the alphabet for blind and visually impaired people).


Communication window on the packaging

We ensure that our product packaging guarantees that the medicine is used safely, and at the same time is accessible for patients and pharmacists. For this purpose, we introduced a special communication window for the prescription medicine packaging system.

The window consists of two fields. One is a fixed space at the back of the packet to be used for the pharmacy price label. This solution avoids obscuring information that is important for the patient, e.g. composition of the medicine, dosage or additional warnings.

The second field makes it easier for patients to remember how to take the medicine. This is because they may lose the separate information they receive from their doctor. The patient may record the dosage scheme of the drugs within the lines corresponding to time of day. This significantly helps to maintain a systematic pattern of taking the medicine and influences the efficacy of the therapy.

Read also

We invite you to read the next articles on our website
Masurian landscape by Marek Wilczura

Environmental responsibility

We attach great importance to harmonious coexistence with the natural environment and we make efforts to minimise the environmental footprint of our manufacturing activities.
read more
People in laboratory

Responsibility for employees

The personnel policy of Polpharma is based on the adopted values, system of professional competencies and open communication. It guarantees equal treatment of employees regardless of their gender, race, background, religion, sexual preferences or disability.
read more
Close-up on holding hands

Public Involvement

We encourage our employees to participate in actions of the employee voluntary services.
read more

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.